Akums Drugs and Pharmaceuticals Limited has announced the incorporation of its wholly owned subsidiary in Malta, Europe, named Akums Healthcare Malta Private Limited, as part of its global expansion strategy.
The company confirmed the development in an official filing dated October 20, 2025, stating that the certificate of registration for the new entity was received the same day. The move follows Akums’ earlier disclosure made on February 6, 2025, regarding its plans to strengthen international operations through overseas subsidiaries.
In the filing, Dharamvir Malik, Company Secretary and Compliance Officer, noted that the incorporation aligns with the company’s strategic objectives to enhance its global footprint and export capabilities.
The new subsidiary is expected to help Akums tap into European healthcare markets, facilitating manufacturing partnerships, contract research, and export opportunities in regulated regions like the EU.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
